Astec Lifesciences (NSE:ASTEC) LT-Debt-to-Total-Asset: 0.05 (As of Mar. 2026)


NSE:ASTEC Astec Lifesciences Ltd NSE:ASTEC
75 GF Score
Price ₹721.95
GF Value ₹983.36
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Astec Lifesciences LT-Debt-to-Total-Asset?

Astec Lifesciences NSE:ASTEC +1.16% 75 LT-Debt-to-Total-Asset is 0.05 as of Mar. 2026. GuruFocus rates NSE:ASTEC with a GF Score™ of 75/100 and a GF Value™ of ₹983.36 (Modestly Undervalued). The stock has 5 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Astec Lifesciences's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.05.

Astec Lifesciences's long-term debt to total assets ratio declined from Mar. 2025 (0.32) to Mar. 2026 (0.05). It may suggest that Astec Lifesciences is progressively becoming less dependent on debt to grow their business.

Astec Lifesciences  (NSE:ASTEC) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Astec Lifesciences LT-Debt-to-Total-Asset Related Terms

Astec Lifesciences LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Astec Lifesciences's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Astec Lifesciences LT-Debt-to-Total-Asset Chart

Astec Lifesciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.01 0.20 0.32 0.05

Astec Lifesciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.32 0.00 0.14 0.00 0.05
NSE:ASTEC
75GF Score
Astec Lifesciences Ltd NSE:ASTEC
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Astec Lifesciences LT-Debt-to-Total-Asset Calculation

Astec Lifesciences's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (A: Mar. 2026 )=Long-Term Debt & Capital Lease Obligation (A: Mar. 2026 )/Total Assets (A: Mar. 2026 )
=500/9420.382
=0.05

Astec Lifesciences's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )/Total Assets (Q: Mar. 2026 )
=500/9420.382
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.05 mean?
Astec Lifesciences (NSE:ASTEC) has a LT-Debt-to-Total-Asset of 0.05 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Astec Lifesciences and its competitors.
Is Astec Lifesciences' LT-Debt-to-Total-Asset too high?
Astec Lifesciences' current LT-Debt-to-Total-Asset is 0.05. Overall, Astec Lifesciences has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astec Lifesciences' LT-Debt-to-Total-Asset compare to CTVA and CF?
Astec Lifesciences' LT-Debt-to-Total-Asset of 0.05 can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for an Agriculture company?
A good LT-Debt-to-Total-Asset depends on the Agriculture industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Astec Lifesciences and its competitors. Astec Lifesciences's current LT-Debt-to-Total-Asset is 0.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astec Lifesciences stock overvalued right now?
Based on GuruFocus' analysis, Astec Lifesciences (NSE:ASTEC) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹983.36, compared to a current price of ₹721.95 — trading 26.6% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.05. Astec Lifesciences' overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Astec Lifesciences (NSE:ASTEC), the current LT-Debt-to-Total-Asset is 0.05 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Astec Lifesciences (NSE:ASTEC) Overvalued in 2026?

Based on GuruFocus' analysis, Astec Lifesciences stock appears to be undervalued. The current stock price of ₹721.95 is trading 26.6% below its estimated GF Value™ of ₹983.36. GuruFocus considers Astec Lifesciences to be Modestly Undervalued.

Key valuation signals for NSE:ASTEC:

  • LT-Debt-to-Total-Asset: 0.05
  • GF Value™: ₹983.36 vs. price of ₹721.95 (26.6% below fair value)
  • GF Score™: 75/100 with 5 warning signs

No single metric tells the full story. See the NSE:ASTEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Astec Lifesciences Business Description

Other Exchanges 533138:India
Address Eastern Express Highway, Godrej One, 3rd Floor, Pirojshanagar, Vikhroli (East), Mumbai, MH, IND, 400 079
Astec Lifesciences Ltd manufactures & distributes a wide range of Agrochemical active ingredients and pharmaceutical intermediates. The company's products include agrochemicals, such as Triazole Fungicides, Herbicides, and Insecticides. The company is also into Intermediates & Specialty chemicals. Geographically, all the operations of the firm function through India; however, its products are sold in the Indian and overseas markets. It operates in the business segment of Agrochemicals and has a business presence in India and outside India.
75GF Score

Get the complete analysis for NSE:ASTEC

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹721.95
Price
₹983.36
GF Value